BTIS
IPXL

BB&T Investment Services’s Impax Laboratories, Inc. IPXL Stock Holding History

BB&T Investment Services’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$1K Buy
+54
New +$990 ﹤0.01% 1410

Other funds holding IPXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TG
TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BB&T Investment Services's IPXL Position: Q4 2017 in Review

BB&T Investment Services opened a new position in Impax Laboratories, Inc. (IPXL) in Q4 2017: 54 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1410 among its holdings.

200 funds tracked by Wall St. Rank hold IPXL as of Q4 2017.

  • BB&T Investment Services held 54 shares of Impax Laboratories, Inc. worth $1K as of Q4 2017.
  • Impax Laboratories, Inc. was a new BB&T Investment Services position in Q4 2017.
  • Impax Laboratories, Inc. made up ﹤0.01% of BB&T Investment Services's portfolio in Q4 2017, its #1410 holding.
  • 200 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.